{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:12:28Z","timestamp":1765545148852},"reference-count":0,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Med Res Opin"],"published-print":{"date-parts":[[2001,2,22]]},"DOI":"10.1185\/030079901750120196","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T22:06:28Z","timestamp":1033509988000},"page":"258-268","source":"Crossref","is-referenced-by-count":26,"title":["Doxofylline: A New Generation Xanthine Bronchodilator Devoid of Major Cardiovascular Adverse Effects"],"prefix":"10.1185","volume":"16","author":[{"given":"Frank Lloyd","family":"Dini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","container-title":["Current Medical Research and Opinion"],"original-title":[],"deposited":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T20:56:13Z","timestamp":1171400173000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.catchword.com\/rpsv\/cgi-bin\/cgi?ini=xref&body=linker&reqdoi=10.1185\/030079901750120196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,22]]},"references-count":0,"journal-issue":{"issue":"4"},"alternative-id":["0300-7995(20010222)16:4L.258;1-"],"URL":"https:\/\/doi.org\/10.1185\/030079901750120196","relation":{},"ISSN":["1473-4877","0300-7995"],"issn-type":[{"value":"1473-4877","type":"electronic"},{"value":"0300-7995","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,22]]}}}